ESC Premium Access

What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

Event: ESC CONGRESS 2019
Topic: Stroke Prevention
Session type: Satellite Symposium
Sponsored by Thrombosis Research Institute
Date: 31 August 2019
Time: 15:30 - 17:00

Congress Session

7 presentations in this session

What have registries taught us? New insights from GARFIELD-AF

Speaker: Professor A. Kakkar (London, GB)
Thumbnail

Long-term outcomes

Speaker: Professor D. Atar (Oslo, NO)
Thumbnail

Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding

Speaker: Professor K. Fox (Edinburgh, GB)
Thumbnail

Changes in antithrombotic therapy after atrial fibrillation diagnosis

Speaker: Doctor F. Cools (Brasschaat, BE)
Thumbnail

Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions

Speaker: Professor J. Camm (London, GB)
Thumbnail

Three-way comparison of effectiveness among different classes of oral anticoagulants: GARFIELD-AF study

Speaker: Professor S. Goto (Isehara, JP)
Thumbnail

The long term impact of atrial fibrillation: closing remarks

Speaker: Professor J. Bassand (Besancon, FR)
Speaker: Doctor B. Gersh (Rochester, US)
Thumbnail

8 speakers from this session

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

Professor Dan Atar

Oslo University Hospital, Oslo (Norway)
11 presentations
0 follower

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
36 presentations
0 follower

Doctor Frank Cools

General Hospital Klina, Brasschaat (Belgium)
1 presentation
0 follower

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)
53 presentations
1 follower

Professor Shinya Goto

Tokai University Hospital, Isehara (Japan)
3 presentations
0 follower

Professor Jean-Pierre Bassand

University Hospital Jean Minjoz, Besancon (France)
5 presentations
0 follower

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)
5 presentations
0 follower

This platform is supported by

logo Novo Nordisk